Laboratory of Agro-Industrial and Medical Biotechnology, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, B.P. 523, Béni Mellal, Morocco.
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3629-3636. doi: 10.31557/APJCP.2023.24.10.3629.
This study investigates the association between HLA-A and -B allele diversity, Fusobacterium nucleatum Fap2 protein-derived antigenic coverage, and colorectal cancer (CRC) epidemiology across diverse populations.
We examined 75 HLA-I alleles and explored 698 potential HLA-A and B-restricted Fap2-derived antigens, assessing how 21 countries may respond to these peptides based on their HLA-I distribution frequencies. Additionally, we correlated in-silico predicted Fap2 population coverage with CRC epidemiology. CRC incidence and mortality data were obtained from the Global Cancer Observatory, and HLA-A and HLA-B allele frequencies from the Allele Frequency Net Database. Binding predictions for Fap2 antigens were performed using netMHCpan4, with stringent selection criteria applied to identify relevant peptides. Population coverage was calculated using the IEDB population coverage tool, and data analysis conducted using the R programming language.
Clustering of HLA-A and -B allele frequencies partially differentiated countries with lower CRC incidence from others. Distinct patterns of Fap2 protein coverage were observed among different populations. interestingly, we found a significant inverse correlation between CRC incidence (p = 0.0037, R = -0.6) and predicted Fap2 antigen coverage, as well as CRC mortality (p = 0.013, R = -0.53). Furthermore, we identified a specific set of Fap2-derived peptides that bind to HLA supertypes, providing a global coverage of 99.04%.
Our population-based study is the first to demonstrate that higher Fap2 coverage is associated with lower CRC incidence, underscoring the potential significance of Fap2-specific CD8+ T cell responses in CRC tumorigenesis.
本研究旨在调查人类白细胞抗原(HLA)-A 和 -B 等位基因多样性、具核梭杆菌 Fap2 蛋白衍生抗原的抗原覆盖范围,以及它们与不同人群结直肠癌(CRC)流行病学之间的关联。
我们检测了 75 个 HLA-I 等位基因,并探索了 698 个可能的 HLA-A 和 B 限制性 Fap2 衍生抗原,评估了基于 HLA-I 分布频率,21 个国家对这些肽的反应情况。此外,我们还将 Fap2 人群覆盖度的计算机预测与 CRC 流行病学进行了相关性分析。CRC 的发病率和死亡率数据来自全球癌症观测站,HLA-A 和 HLA-B 等位基因频率来自 Allele Frequency Net 数据库。使用 netMHCpan4 进行 Fap2 抗原的结合预测,采用严格的选择标准来鉴定相关肽。使用 IEDB 人群覆盖工具计算人群覆盖度,并使用 R 编程语言进行数据分析。
HLA-A 和 -B 等位基因频率的聚类部分区分了 CRC 发病率较低的国家和其他国家。不同人群中观察到 Fap2 蛋白覆盖范围存在不同的模式。有趣的是,我们发现 CRC 发病率(p = 0.0037,R = -0.6)和预测的 Fap2 抗原覆盖度之间存在显著的负相关,以及 CRC 死亡率(p = 0.013,R = -0.53)。此外,我们鉴定出一组与 HLA 超型结合的特定 Fap2 衍生肽,提供了 99.04%的全球覆盖度。
本基于人群的研究首次表明,较高的 Fap2 覆盖度与较低的 CRC 发病率相关,突出了 Fap2 特异性 CD8+ T 细胞反应在 CRC 肿瘤发生中的潜在意义。